No article text was recorded for this version.
abscopal effect induction
Version 1 of 128 papers34 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Intratumoral Injection of Engineered <i>Mycobacterium smegmatis</i> Induces Antitumor Immunity and Inhibits Tumor Growth
- Blog: Efficacy and safety of immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis
- Blog: Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2
- Blog: 1132 Impact of intralesional oncolytic viral therapy targeting <i>in situ</i> activation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients
- Blog: Pathological complete response in MMR-deficient/MSI-high and KRAS-mutant patient with locally advanced rectal cancer after neoadjuvant chemoradiation with immunotherapy: A case report
- Blog: Primary vaginal malignant melanoma successfully treated with combination therapy: A case report
- Blog: Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation
- Blog: Viral‐Directed Augmentation of Kupffer Cell Cross‐Presentation Provokes Antitumor Immunity Against Liver Metastasis
- Blog: Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis
- Blog: Case report: ALK-positive histiocytosis presented as bilateral synchronous breast masses with long-term remission on crizotinib
- Blog: In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
- Blog: Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study
- Blog: Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy
- Blog: Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages
- Blog: Tumor Environment Regression Therapy Implemented by Switchable Prune‐to‐Essence Nanoplatform Unleashed Systemic Immune Responses
- Blog: Personalized SO2 Prodrug for pH-Triggered Gas Enhancement in Anti-Tumor Radio-Immunotherapy
- Blog: Supramolecular Photothermal Nanomedicine Mediated Distant Tumor Inhibition via PD-1 and TIM-3 Blockage
- Blog: 576 Comprehensive single cell sequencing analysis of paired tissue and blood samples from HCC patients treated with neoadjuvant anti-PD-1 therapy reveals treatment-induced clonal T cell dynamics
- Blog: Spatholobus Suberectus Column Extract Suppresses Dendritic Cell Maturation and has Therapeutic Potential for Psoriasis
- Blog: Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system
- Blog: How to improve photodynamic therapy-induced antitumor immunity for cancer treatment?
- Blog: Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis
- Blog: Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma
- Blog: NIR-II light-driven <i>in situ</i> nanovaccine for cancer immunotherapy via lymph node migration-mediated accumulation
- Blog: RNA-seq liver transcriptome analysis reveals an activated MHC-I pathway and an inhibited MHC-II pathway at the early stage of vaccine immunization in zebrafish
- Blog: The therapeutic effect of radiotherapy combined with systemic therapy compared to radiotherapy alone in patients with simple brain metastasis after first-line treatment of limited-stage small cell lung cancer: a retrospective study
- Blog: Combination Therapy with Local Radiofrequency Ablation and Systemic Vaccine Enhances Antitumor Immunity and Mediates Local and Distal Tumor Regression
- Blog: Histotripsy Ablation in Preclinical Animal Models of Cancer and Spontaneous Tumors in Veterinary Patients: A Review
History & citation
Current · Permanent link
- This direction split from In Situ Vaccination for Systemic Cancer Control (82% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_abscopal_effect_induction_1e6c5ee9,
title = {abscopal effect induction},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/abscopal-effect-induction/rdr_1e6c5ee9cfa747b1b1ac872f414b6022},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_abscopal_effect_induction_1e6c5ee9_v1,
title = {abscopal effect induction},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/abscopal-effect-induction/rdr_1e6c5ee9cfa747b1b1ac872f414b6022/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}